Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: New Haven
State: Connecticut
Zip:
Country: United States
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration, dense deposit disease, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. The company was founded in 2005 and is based in New Haven, Connecticut.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2009 | Debt Financing | $5M | 10/2007 | Series A | 5 | $37M |
Domain Associates GE Healthcare Johnson &a; Johnson Development Corporation Pappas Ventures Quaker BioVentures Domain Associates GE Healthcare Johnson &a; Johnson Development Corporation Pappas Ventures Quaker BioVentures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|